A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

作者:Popat Rakesh*; Plesner Torben; Davies Faith; Cook Gordon; Cook Mark; Elliott Peter; Jacobson Eric; Gumbleton Todd; Oakervee Heather; Cavenagh Jamie
来源:British Journal of Haematology, 2013, 160(5): 714-717.
DOI:10.1111/bjh.12154